| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 44 |
| 1 | METHOTREXATE SODIUM | 34 |
| 2 | METHOTREXATE | 25 |
| 3 | ADALIMUMAB-AATY | 20 |
| 4 | ADALIMUMAB-ADAZ | 20 |
| 5 | ADALIMUMAB-FKJP | 20 |
| 6 | PREDNISONE | 19 |
| 7 | INFLIXIMAB | 13 |
| 8 | AZATHIOPRINE | 9 |
| 9 | ETANERCEPT | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 6 | 0.0017 |
| 1 | BODY CLEANSER | 1 | 0.0014 |
| 2 | RITLECITINIB | 1 | 0.0005 |
| 3 | ADALIMUMAB-FKJP | 20 | 0.0004 |
| 4 | ADALIMUMAB-AATY | 20 | 0.0004 |
| 5 | SKIN PROTECTANT | 1 | 0.0004 |
| 6 | ADALIMUMAB-ADAZ | 20 | 0.0004 |
| 7 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 | 0.0004 |
| 8 | ESTROGEN | 1 | 0.0003 |
| 9 | FLUOCINOLONE ACETONIDE | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 42 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 25 |
| 2 | Corticosteroid [EPC] | 23 |
| 3 | Purine Antimetabolite [EPC] | 9 |
| 4 | Interferon beta [EPC] | 8 |
| 5 | Nucleoside Analog Antiviral [EPC] | 7 |
| 6 | Vitamin D [EPC] | 7 |
| 7 | Benzodiazepine [EPC] | 6 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 6 |
| 9 | Vitamin B12 [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | CD19-directed Cytolytic Antibody [EPC] | 1 | 0.0012 |
| 2 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 3 | Purine Antimetabolite [EPC] | 9 | 0.0001 |
| 4 | Nucleoside Analog Antiviral [EPC] | 7 | 0.0001 |
| 5 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 6 | Influenza A M2 Protein Inhibitor [EPC] | 1 | 0.0001 |
| 7 | Anticholinergic [EPC] | 1 | 0.0001 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 25 | 0.0001 |
| 9 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |